These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 37011669)
1. Transgender health and the impact of aging and menopause. Cheung AS; Nolan BJ; Zwickl S Climacteric; 2023 Jun; 26(3):256-262. PubMed ID: 37011669 [TBL] [Abstract][Full Text] [Related]
2. Gender-affirming hormone therapy for transgender and gender-diverse adults in Australia. Nolan BJ; Cheung AS Intern Med J; 2024 Sep; 54(9):1450-1457. PubMed ID: 39056542 [TBL] [Abstract][Full Text] [Related]
3. Clinicians in the Veterans Health Administration initiate gender-affirming hormone therapy in concordance with clinical guideline recommendations. Jasuja GK; Wolfe HL; Reisman JI; Vimalananda VG; Rao SR; Blosnich JR; Livingston NA; Shipherd JC Front Endocrinol (Lausanne); 2024; 15():1086158. PubMed ID: 38800485 [TBL] [Abstract][Full Text] [Related]
4. Feminizing gender-affirming hormone therapy for the transgender and gender diverse population: An overview of treatment modality, monitoring, and risks. Sudhakar D; Huang Z; Zietkowski M; Powell N; Fisher AR Neurourol Urodyn; 2023 Jun; 42(5):903-920. PubMed ID: 36403287 [TBL] [Abstract][Full Text] [Related]
5. Hormone Concentrations in Transgender Women Who Self-Prescribe Gender Affirming Hormone Therapy: A Retrospective Study. Salakphet T; Mattawanon N; Manojai N; Muangmool T; Tangpricha V J Sex Med; 2022 May; 19(5):864-871. PubMed ID: 35379590 [TBL] [Abstract][Full Text] [Related]
6. Assessing and Addressing the Risk of Venous Thromboembolism Across the Spectrum of Gender Affirming Care: A Review. Arrington-Sanders R; Connell NT; Coon D; Dowshen N; Goldman AL; Goldstein Z; Grimstad F; Javier NM; Kim E; Murphy M; Poteat T; Radix A; Schwartz A; St Amand C; Streed CG; Tangpricha V; Toribio M; Goldstein RH Endocr Pract; 2023 Apr; 29(4):272-278. PubMed ID: 36539066 [TBL] [Abstract][Full Text] [Related]
7. Longitudinal Changes in Liver Enzyme Levels Among Transgender People Receiving Gender Affirming Hormone Therapy. Hashemi L; Zhang Q; Getahun D; Jasuja GK; McCracken C; Pisegna J; Roblin D; Silverberg MJ; Tangpricha V; Vupputuri S; Goodman M J Sex Med; 2021 Sep; 18(9):1662-1675. PubMed ID: 34366264 [TBL] [Abstract][Full Text] [Related]
8. Transgender patients and gender-affirming hormone therapy through the mid-life. Mehta JM; Kanell S; Borowicz CEA; Fisher MA Maturitas; 2024 Nov; 189():108093. PubMed ID: 39178607 [TBL] [Abstract][Full Text] [Related]
9. Gender-affirming hormone therapy induces specific DNA methylation changes in blood. Shepherd R; Bretherton I; Pang K; Mansell T; Czajko A; Kim B; Vlahos A; Zajac JD; Saffery R; Cheung A; Novakovic B Clin Epigenetics; 2022 Feb; 14(1):24. PubMed ID: 35177097 [TBL] [Abstract][Full Text] [Related]
10. Gender-Affirming Hormone Treatment and Metabolic Syndrome Among Transgender Veterans. Hashemi L; Marijic Buljubasic A; Budoff MJ; Copeland LA; Jackson NJ; Jasuja GK; Gornbein J; Reue K JAMA Netw Open; 2024 Jul; 7(7):e2419696. PubMed ID: 38954413 [TBL] [Abstract][Full Text] [Related]
11. Gender minority stress in transgender people: a major role for social network. Collet S; Kiyar M; Martens K; Vangeneugden J; Simpson VG; Guillamon A; Mueller SC; T'Sjoen G J Sex Med; 2023 May; 20(6):905-917. PubMed ID: 37102304 [TBL] [Abstract][Full Text] [Related]
12. Short-Term Effects of Gender-Affirming Hormone Therapy on Dysphoria and Quality of Life in Transgender Individuals: A Prospective Controlled Study. Foster Skewis L; Bretherton I; Leemaqz SY; Zajac JD; Cheung AS Front Endocrinol (Lausanne); 2021; 12():717766. PubMed ID: 34394009 [TBL] [Abstract][Full Text] [Related]
13. Gender-Affirming Hormone Use in Transgender Individuals: Impact on Behavioral Health and Cognition. Nguyen HB; Chavez AM; Lipner E; Hantsoo L; Kornfield SL; Davies RD; Epperson CN Curr Psychiatry Rep; 2018 Oct; 20(12):110. PubMed ID: 30306351 [TBL] [Abstract][Full Text] [Related]
14. Sex hormones, insomnia, and sleep quality: Subjective sleep in the first year of hormone use in transgender persons. Morssinkhof MWL; Wiepjes CM; Bosman BW; Kinds J; Fisher AD; Greenman Y; Kreukels BPC; T'Sjoen G; van der Werf YD; Heijer MD; Broekman BFP Sleep Med; 2023 Jul; 107():316-326. PubMed ID: 37271109 [TBL] [Abstract][Full Text] [Related]
15. Long-term effect of gender-affirming hormone treatment on depression and anxiety symptoms in transgender people: A prospective cohort study. Aldridge Z; Patel S; Guo B; Nixon E; Pierre Bouman W; Witcomb GL; Arcelus J Andrology; 2021 Nov; 9(6):1808-1816. PubMed ID: 32777129 [TBL] [Abstract][Full Text] [Related]
16. Routine Screening for Transgender and Gender Diverse Adults Taking Gender-Affirming Hormone Therapy: a Narrative Review. Iwamoto SJ; Grimstad F; Irwig MS; Rothman MS J Gen Intern Med; 2021 May; 36(5):1380-1389. PubMed ID: 33547576 [TBL] [Abstract][Full Text] [Related]